26 results on '"Katsube R"'
Search Results
2. Reconstruction of dendritic growth by fast tomography and phase field filtering
- Author
-
Yasuda, H, primary, Nishiguchi, A, additional, Xue, H, additional, Nonomura, M, additional, Nakano, K, additional, Katsube, R, additional, Narumi, T, additional, and Takaki, T, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Observation of grain motion during semisolid deformation by using 4D-CT and 3DXRD
- Author
-
Narumi, T, primary, Ohta, K, additional, Ohta, M, additional, Numata, T, additional, Asahi, K, additional, Katsube, R, additional, and Yasuda, H, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Microstructure evolution induced by solidification and ferrite–austenite massive-like transformation in Fe–C alloys
- Author
-
Tsuji, S, primary, Nanri, T, additional, Narumi, T, additional, Katsube, R, additional, and Yasuda, H, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Synthesis of alkaline-earth Zintl phosphides MZn2P2 (M = Ca, Sr, Ba) from Sn solutions
- Author
-
Katsube Ryoji and Nose Yoshitaro
- Subjects
photovoltaics ,solution growth ,optoelectronic characterization ,buffer layer ,emitter ,Technology ,Chemical technology ,TP1-1185 ,Chemicals: Manufacture, use, etc. ,TP200-248 - Abstract
Exploration of suitable partner materials (so-called buffer layer or n-type emitter) for each light-absorbing material is essential to practicalize various emerging photovoltaic devices. Motivated by our recent discovery of a partner material, Mg(MgxZn1−x )2P2, in Mg/Zn3P2 solar cells, the related series of materials MZn2P2 (M = Ca, Sr, Ba) is of interest to the application in pnictide-based solar cells. In this study, we synthesize these materials to evaluate the optoelectronic properties concerning photovoltaic applications. To deal with the difficulties of the high vapor pressure and reactivity of the constituent elements, we utilized Sn as a solvent to reduce their activities during heat treatments. Powders that are mainly composed of MZn2P2 were obtained by crushing the samples after solution growth, although single-phase crystals of MZn2P2 could not be obtained in this study. The optical bandgap and the ionization potential of each MZn2P2 were evaluated through the diffuse reflectance and the photoelectron yield spectroscopy measurements of the powder. As a result, we found that CaZn2P2 would be a promising partner material in photovoltaics based on Zn3P2 and ZnSnP2.
- Published
- 2022
- Full Text
- View/download PDF
6. Successful Bronchoscopic Treatment for Postoperative Bronchopleural Fistula Using N-butyl-2-cyanoacrylate (NBCA): Report of a Post-completion Pneumonectomy Case with a History of Induction Chemoradiotherapy Followed by Bilobectomy for Advanced Lung Cancer
- Author
-
Shiotani, T., Yamamoto, H., Katsube, R., Tomioka, Y., Suzawa, K., Miyoshi, K., Otani, S., Okazaki, M., Seiichiro Sugimoto, Soh, J., Yamane, M., and Toyooka, S.
- Subjects
Male ,Lung Neoplasms ,bronchopleural fistula ,n-butyl-2-cyanoacrylate (NBCA) ,Chemoradiotherapy, Adjuvant ,Enbucrilate ,Middle Aged ,Postoperative Complications ,omental pedicled flap ,Bronchoscopy ,Humans ,induction chemoradiotherapy ,Bronchial Fistula ,pneumonectomy - Abstract
Bronchopleural fistula (BPF) is a severe complication following lung resection. We present the case of a patient with a history of advanced lung cancer, who had undergone induction chemoradiotherapy followed by right middle and lower lobectomy, and who developed BPF after completion right pneumonectomy. Although we had covered the bronchial stump with an omental pedicled flap, BPF was found on postoperative day 19. We covered the fistula with n-butyl-2-cyanoacrylate (NBCA) using bronchoscopy. Although we had to repeat the NBCA treatment, we ultimately cured the patient's BPF and no recurrence was observed up to 15.2 months after surgery.
7. Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer
- Author
-
Noma, K., Kashima, H., Ninomiya, T., Katsube, R., Watanabe, S., Ohara, T., Tazawa, H., Shunsuke Kagawa, Shirakawa, Y., and Fujiwara, T.
8. Theoretical and data-driven approaches to semiconductors and dielectrics: from prediction to experiment.
- Author
-
Oba F, Nagai T, Katsube R, Mochizuki Y, Tsuji M, Deffrennes G, Hanzawa K, Nakano A, Takahashi A, Terayama K, Tamura R, Hiramatsu H, Nose Y, and Taniguchi H
- Abstract
Computational approaches using theoretical calculations and data scientific methods have become increasingly important in materials science and technology, with the development of relevant methodologies and algorithms, the availability of large materials data, and the enhancement of computer performance. As reviewed herein, we have developed computational methods for the design and prediction of inorganic materials with a particular focus on the exploration of semiconductors and dielectrics. High-throughput first-principles calculations are used to systematically and accurately predict the local atomic and electronic structures of polarons, point defects, surfaces, and interfaces, as well as bulk fundamental properties. Machine learning techniques are utilized to efficiently predict various material properties, construct phase diagrams, and search for materials satisfying target properties. These computational approaches have elucidated the mechanisms behind material functionalities and explored promising materials in combination with synthesis, characterization, and device fabrication. Examples include the development of ternary nitride semiconductors for potential optoelectronic and photovoltaic applications, the exploration of phosphide semiconductors and the optimization of heterointerfaces toward the improvement of phosphide-based photovoltaic cells, and the discovery of ferroelectricity in layered perovskite oxides and the theoretical understanding of its origin, all of which demonstrate the effectiveness of our computer-aided materials research., Competing Interests: No potential conflict of interest was reported by the author(s)., (© 2024 The Author(s). Published by National Institute for Materials Science in partnership with Taylor & Francis Group.)
- Published
- 2024
- Full Text
- View/download PDF
9. Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children.
- Author
-
Tatebe Y, Ushio S, Esumi S, Sada H, Ochi M, Tamefusa K, Ishida H, Fujiwara K, Kanamitsu K, Washio K, Katsube R, Murakawa K, and Zamami Y
- Subjects
- Adult, Child, Humans, Acyclovir pharmacology, Acyclovir therapeutic use, Herpesvirus 3, Human physiology, Retrospective Studies, Transplantation, Homologous adverse effects, Virus Activation, Antiviral Agents therapeutic use, Herpes Zoster etiology, Herpes Zoster prevention & control, Herpes Zoster drug therapy, Hematopoietic Stem Cell Transplantation adverse effects
- Abstract
Background: Varicella-zoster virus (VZV) reactivation is a serious complication of hematopoietic stem cell transplantation (HSCT). Although low-dose acyclovir can prevent VZV reactivation after HSCT in adults, the efficacy of a dose of acyclovir lower than the recommended dose, such as 60-80 mg/kg/day in children, is unclear. In this study, we aimed to evaluate the incidence of VZV reactivation after HSCT during and after low-dose acyclovir administration for preventing VZV reactivation in children., Methods: This single-center retrospective study included children aged ≤15 years who received oral acyclovir (at 15 mg/kg/day) to prevent VZV reactivation after HSCT. We examined the cumulative incidence of VZV reactivation after HSCT, during and after prophylactic acyclovir administration., Results: Fifty-three eligible patients were included in this study, of whom 37 underwent allogeneic HSCT. The median duration of prophylactic acyclovir therapy was 264 days (range: 69-1140 days). VZV reactivation occurred in 13 patients (24.5%, 95% confidence interval [CI]: 14.9-37.6). The cumulative incidence of VZV reactivation 1 and 2 years after HSCT was 6.26% (95% CI: 1.60-15.5) and 20.9% (95% CI: 10.3-34.0), respectively. While only one patient developed VZV reactivation during the administration of prophylactic acyclovir, the cumulative incidence of VZV reactivation increased to 24.2% (95% CI: 12.5-38.0) 1 year after the cessation of acyclovir., Conclusion: Low-dose acyclovir (15 mg/kg/day) could be effective for preventing VZV reactivation after HSCT in children because VZV reactivation seldom occurs during the administration of 15 mg/kg/day acyclovir., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
10. Optical and Electrical Transport Evaluations of n-Type Iron Pyrite Single Crystals.
- Author
-
Uchiyama S, Sato R, Katsube R, Islam MM, Adachi H, Sakurai T, Nose Y, and Ishikawa Y
- Abstract
Iron pyrite [cubic FeS
2 (cFeS2 )] is considered as an earth-abundant and low-cost thin-film photovoltaic material. However, the conversion efficiency of cFeS2 -based solar cells remains below 3%. To elucidate this limitation, we evaluate the optical and electrical characteristics of cFeS2 single crystals that are grown using the flux method, thus providing us an understanding of the electron transport behavior of cFeS2 single crystals. The oxide layer on the surface of cFeS2 , which can possibly have an influence on the electrical characteristics of cFeS2 , is removed prior to characterization via optical spectroscopy and electrical transport measurement. The optical property of cFeS2 was found to have both indirect and direct transitions. We also observed the presence of a band tail below the conduction band. The obtained electrical transport behavior indicates that cFeS2 bulk exhibits a high defect density and a disordered phase, thus leading to the hopping conduction mechanism. Our results will pave the way for the development of photovoltaic applications with iron pyrite., Competing Interests: The authors declare no competing financial interest., (© 2021 The Authors. Published by American Chemical Society.)- Published
- 2021
- Full Text
- View/download PDF
11. Successful Bronchoscopic Treatment for Postoperative Bronchopleural Fistula Using N-butyl-2-cyanoacrylate (NBCA): Report of a Post-completion Pneumonectomy Case with a History of Induction Chemoradiotherapy Followed by Bilobectomy for Advanced Lung Cancer.
- Author
-
Shiotani T, Yamamoto H, Katsube R, Tomioka Y, Suzawa K, Miyoshi K, Otani S, Okazaki M, Sugimoto S, Soh J, Yamane M, and Toyooka S
- Subjects
- Bronchial Fistula diagnostic imaging, Bronchial Fistula etiology, Bronchoscopy, Chemoradiotherapy, Adjuvant adverse effects, Humans, Lung Neoplasms therapy, Male, Middle Aged, Postoperative Complications drug therapy, Postoperative Complications etiology, Bronchial Fistula therapy, Enbucrilate therapeutic use, Pneumonectomy adverse effects
- Abstract
Bronchopleural fistula (BPF) is a severe complication following lung resection. We present the case of a patient with a history of advanced lung cancer, who had undergone induction chemoradiotherapy followed by right middle and lower lobectomy, and who developed BPF after completion right pneumonectomy. Although we had covered the bronchial stump with an omental pedicled flap, BPF was found on postoperative day 19. We covered the fistula with n-butyl-2-cyanoacrylate (NBCA) using bronchoscopy. Although we had to repeat the NBCA treatment, we ultimately cured the patient's BPF and no recurrence was observed up to 15.2 months after surgery., Competing Interests: No potential conflict of interest relevant to this article was reported.
- Published
- 2021
- Full Text
- View/download PDF
12. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
- Author
-
Katsube R, Noma K, Ohara T, Nishiwaki N, Kobayashi T, Komoto S, Sato H, Kashima H, Kato T, Kikuchi S, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, and Fujiwara T
- Subjects
- Animals, Antimetabolites, Antineoplastic pharmacology, Apoptosis drug effects, Cell Proliferation drug effects, Drug Resistance, Neoplasm, Endopeptidases immunology, Esophageal Neoplasms immunology, Esophageal Neoplasms metabolism, Esophageal Neoplasms pathology, Female, Fluorouracil pharmacology, Humans, Immunoconjugates pharmacology, Membrane Proteins immunology, Mice, Mice, Inbred BALB C, Mice, Nude, Photosensitizing Agents pharmacology, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Cancer-Associated Fibroblasts immunology, Esophageal Neoplasms therapy, Immunotherapy methods, Membrane Proteins antagonists & inhibitors, Phototherapy methods
- Abstract
Cancer-associated fibroblasts (CAFs) have an important role in the tumor microenvironment. CAFs have the multifunctionality which strongly support cancer progression and the acquisition of therapeutic resistance by cancer cells. Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer treatment that uses a highly selective monoclonal antibody (mAb)-photosensitizer conjugate. We developed fibroblast activation protein (FAP)-targeted NIR-PIT, in which IR700 was conjugated to a FAP-specific antibody to target CAFs (CAFs-targeted NIR-PIT: CAFs-PIT). Thus, we hypothesized that the control of CAFs could overcome the resistance to conventional chemotherapy in esophageal cancer (EC). In this study, we evaluated whether EC cell acquisition of stronger malignant characteristics and refractoriness to chemoradiotherapy are mediated by CAFs. Next, we assessed whether the resistance could be rescued by eliminating CAF stimulation by CAFs-PIT in vitro and in vivo. Cancer cells acquired chemoradiotherapy resistance via CAF stimulation in vitro and 5-fluorouracil (FU) resistance in CAF-coinoculated tumor models in vivo. CAF stimulation promoted the migration/invasion of cancer cells and a stem-like phenotype in vitro, which were rescued by elimination of CAF stimulation. CAFs-PIT had a highly selective effect on CAFs in vitro. Finally, CAF elimination by CAFs-PIT in vivo demonstrated that the combination of 5-FU and NIR-PIT succeeded in producing 70.9% tumor reduction, while 5-FU alone achieved only 13.3% reduction, suggesting the recovery of 5-FU sensitivity in CAF-rich tumors. In conclusion, CAFs-PIT could overcome therapeutic resistance via CAF elimination. The combined use of novel targeted CAFs-PIT with conventional anticancer treatments can be expected to provide a more effective and sensible treatment strategy.
- Published
- 2021
- Full Text
- View/download PDF
13. Preparation of a CuGaSe 2 single crystal and its photocathodic properties.
- Author
-
Ikeda S, Fujita W, Okamoto R, Nose Y, Katsube R, Yoshino K, and Harada T
- Abstract
Chalcopyrite CuGaSe
2 single crystals were successfully synthesized by the flux method using a home-made Bridgman-type furnace. The grown crystals were nearly stoichiometric with a Se-poor composition. Although a wafer form of the thus-obtained single crystal showed poor p-type electrical properties due to such unfavorable off-stoichiometry, these properties were found to be improved by applying a post-annealing treatment under Se vapor conditions. As a result, an electrode derived from the Se-treated single crystalline wafer showed appreciable p-type photocurrents. After deposition of a CdS ultrathin layer and a nanoparticulate Pt catalyst on the surface of the electrode, appreciable photoelectrochemical H2 evolution was observed over the modified electrode under photoirradiation by simulated sunlight with application of a bias potential of 0 VRHE ., Competing Interests: There are no conflicts to declare., (This journal is © The Royal Society of Chemistry.)- Published
- 2020
- Full Text
- View/download PDF
14. Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
- Author
-
Kashima H, Noma K, Ohara T, Kato T, Katsura Y, Komoto S, Sato H, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, and Fujiwara T
- Subjects
- Aged, Animals, Cell Line, Tumor, Cell Movement, Female, Humans, Lymphatic Metastasis, Male, Mice, Inbred BALB C, Mice, Nude, Middle Aged, Survival Analysis, Transplantation, Heterologous, Cancer-Associated Fibroblasts pathology, Carcinoma, Squamous Cell pathology, Esophageal Neoplasms pathology, Tumor Microenvironment
- Abstract
Lymph node metastasis is a pathognomonic feature of spreading tumors, and overcoming metastasis is a challenge in attaining more favorable clinical outcomes. Esophageal cancer is an aggressive tumor for which lymph node metastasis is a strong poor prognostic factor, and the tumor microenvironment (TME), and cancer-associated fibroblasts (CAFs) in particular, has been implicated in esophageal cancer progression. CAFs play a central role in the TME and have been reported to provide suitable conditions for the progression of esophageal cancer, similar to their role in other malignancies. However, little is known concerning the relevance of CAFs to the lymph node metastasis of esophageal cancer. Here, we used clinical samples of esophageal cancer to reveal that CAFs promote lymph node metastasis and subsequently verified the intercellular relationships in vitro and in vivo using an orthotopic metastatic mouse model. In the analysis of clinical samples, FAP
+ CAFs were strongly associated with lymph node metastasis rather than with other prognostic factors. Furthermore, CAFs affected the ability of esophageal cancer cells to acquire metastatic phenotypes in vitro; this finding was confirmed by data from an in vivo orthotopic metastatic mouse model showing that the number of lymph node metastases increased upon injection of cocultured cancer cells and CAFs. In summary, we verified in vitro and in vivo that the accumulation of CAFs enhances the lymph node metastasis of ESCC. Our data suggest that CAF targeted therapy can reduce lymph node metastasis and improve the prognosis of patients with esophageal cancer in the future., (© 2018 UICC.)- Published
- 2019
- Full Text
- View/download PDF
15. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
- Author
-
Watanabe S, Noma K, Ohara T, Kashima H, Sato H, Kato T, Urano S, Katsube R, Hashimoto Y, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, and Fujiwara T
- Subjects
- Animals, Cancer-Associated Fibroblasts pathology, Cell Line, Tumor, Cell Survival drug effects, Disease Progression, Endopeptidases, Esophageal Squamous Cell Carcinoma therapy, Humans, Immunotherapy, Mice, Photosensitizing Agents pharmacology, Phototherapy, Tumor Microenvironment drug effects, Tumor Microenvironment immunology, Xenograft Model Antitumor Assays, Cancer-Associated Fibroblasts metabolism, Esophageal Squamous Cell Carcinoma metabolism, Esophageal Squamous Cell Carcinoma pathology, Gelatinases antagonists & inhibitors, Gelatinases metabolism, Membrane Proteins antagonists & inhibitors, Membrane Proteins metabolism, Serine Endopeptidases metabolism
- Abstract
Cancer-associated fibroblasts (CAFs) are strongly implicated in tumor progression, including in the processes of tumorigenesis, invasion, and metastasis. The targeting of CAFs using various therapeutic approaches is a novel treatment strategy; however, the efficacy of such therapies remains limited. Recently, near-infrared photoimmunotherapy (NIR-PIT), which is a novel targeted therapy employing a cell-specific mAb conjugated to a photosensitizer, has been introduced as a new type of phototherapy. In this study, we have developed a novel NIR-PIT technique to target CAFs, by focusing on fibroblast activation protein (FAP), and we evaluate the treatment efficacy in vitro and in vivo . Esophageal carcinoma cells exhibited enhanced activation of fibroblasts, with FAP over-expressed in the cytoplasm and on the cell surface. FAP-IR700-mediated PIT showed induced rapid cell death specifically for those cells in vitro and in vivo , without adverse effects. This novel therapy for CAFs, designed as local control phototherapy, was safe and showed a promising inhibitory effect on FAP
+ CAFs. PIT targeting CAFs via the specific marker FAP may be a therapeutic option for CAFs in the tumor microenvironment in the future.- Published
- 2019
- Full Text
- View/download PDF
16. Reactive Epitaxial Formation of a Mg-P-Zn Ternary Semiconductor in Mg/Zn 3 P 2 Solar Cells.
- Author
-
Katsube R, Kazumi K, Tadokoro T, and Nose Y
- Abstract
Zinc phosphide (Zn
3 P2 ) has attracted considerable attention as an environmentally benign and earth-abundant photoabsorber for thin-film photovoltaics. It is known that interdiffusion occurs at the Mg/Zn3 P2 interface, which is a component of the record device, but the micro- and nanoscopic structures of the interface after interdiffusion have been controversial for over three decades. Here, we report on the formation of a Mg-P-Zn ternary semiconductor, Mg(Mgx Zn1- x )2 P2 , at the Mg/Zn3 P2 interface. Interestingly, Mg(Mgx Zn1- x )2 P2 is epitaxially grown on Zn3 P2 with the orientation relationship of [21̅1̅0](0001)Mg(Mg ||[100](011)x Zn1- x )Zn due to interdiffusion. The lattice mismatch of the Mg(Mg3 P2 x Zn1- x )2 P2 layer on the Zn3 P2 substrate is less than 0.5%, and this is favorable for carrier transport across the interface. Mg(Mgx Zn1- x )2 P2 is the material suggested as "n-type Mg-doped Zn3 P2 " or "a Mg-P-Zn alloy" in the previous studies. Thus, only the optimization of Mg treatment as conducted in the previous studies is insufficient for the improvement of the cell performance. This work clarified that a suitable microstructure and band structure around Mg(Mgx Zn1- x )2 P2 /Zn3 P2 heterointerface should be established.- Published
- 2018
- Full Text
- View/download PDF
17. Cancer-Associated Fibroblasts Affect Intratumoral CD8 + and FoxP3 + T Cells Via IL6 in the Tumor Microenvironment.
- Author
-
Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, and Fujiwara T
- Subjects
- Aged, Animals, Cancer-Associated Fibroblasts immunology, Cell Line, Tumor, Esophageal Neoplasms genetics, Esophageal Neoplasms pathology, Female, Forkhead Transcription Factors genetics, Forkhead Transcription Factors immunology, Gene Expression Regulation, Neoplastic immunology, Heterografts, Humans, Interleukin-6 genetics, Lymphocytes, Tumor-Infiltrating immunology, Male, Mice, Tumor Microenvironment immunology, Cancer-Associated Fibroblasts pathology, Esophageal Neoplasms immunology, Lymphocytes, Tumor-Infiltrating pathology, Tumor Microenvironment genetics
- Abstract
Purpose: Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) play a central role in tumor progression. We investigated whether CAFs can regulate tumor-infiltrating lymphocytes (TILs) and their role in tumor immunosuppression. Experimental Design: A total of 140 cases of esophageal cancer were analyzed for CAFs and CD8
+ or forkhead box protein 3 (FoxP3+ ) TILs by IHC. We analyzed cytokines using murine or human fibroblasts and cancer cells. Murine-derived fibroblasts and cancer cells were also inoculated into BALB/c or BALB/c- nu/nu mice and the tumors treated with recombinant IL6 or anti-IL6 antibody. Results: CD8+ TILs and CAFs were negatively correlated in intratumoral tissues ( P < 0.001), whereas FoxP3+ TILs were positively correlated ( P < 0.001) in esophageal cancers. Cocultured Colon26 cancer cells and fibroblasts resulted in accelerated tumor growth in BALB/c mice, along with decreased CD8+ and increased FoxP3+ TILs, compared with cancer cells alone. In vitro , IL6 was highly secreted in both murine and human cancer cell/fibroblast cocultures. IL6 significantly increased Colon26 tumor growth in immune-competent BALB/c ( P < 0.001) with fewer CD8+ TILs than untreated tumors ( P < 0.001), whereas no difference in BALB/c- nu/nu mice. In contrast, FoxP3+ TILs increased in IL6-treated tumors ( P < 0.001). IL6 antibody blockade of tumors cocultured with fibroblasts resulted not only in regression of tumor growth but also in the accumulation of CD8+ TILs in intratumoral tissues. Conclusions: CAFs regulate immunosuppressive TIL populations in the TME via IL6. IL6 blockade, or targeting CAFs, may improve preexisting tumor immunity and enhance the efficacy of conventional immunotherapies. Clin Cancer Res; 24(19); 4820-33. ©2018 AACR ., (©2018 American Association for Cancer Research.)- Published
- 2018
- Full Text
- View/download PDF
18. Iron depletion is a novel therapeutic strategy to target cancer stem cells.
- Author
-
Ninomiya T, Ohara T, Noma K, Katsura Y, Katsube R, Kashima H, Kato T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Chen L, Kasai T, Seno M, Matsukawa A, and Fujiwara T
- Abstract
Adequate iron levels are essential for human health. However, iron overload can act as catalyst for the formation of free radicals, which may cause cancer. Cancer stem cells (CSCs), which maintain the hallmark stem cell characteristics of self-renewal and differentiation capacity, have been proposed as a driving force of tumorigenesis and metastases. In the present study, we investigated the role of iron in the proliferation and stemness of CSCs, using the miPS-LLCcm cell model. Although the anti-cancer agents fluorouracil and cisplatin suppressed the proliferation of miPS-LLCcm cells, these drugs did not alter the expression of stemness markers, including Nanog, SOX2, c-Myc, Oct3/4 and Klf4. In contrast, iron depletion by the iron chelators deferasirox and deferoxamine suppressed the proliferation of miPS-LLCcm cells and the expression of stemness markers. In an allograft model, deferasirox inhibited the growth of miPS-LLCcm implants, which was associated with decreased expression of Nanog and Sox2. Altogether, iron appears to be crucial for the proliferation and maintenance of stemness of CSCs, and iron depletion may be a novel therapeutic strategy to target CSCs., Competing Interests: CONFLICTS OF INTEREST The authors have declared that no competing interests exist.
- Published
- 2017
- Full Text
- View/download PDF
19. Application of ultrasound-guided selective sensory nerve block for the endovascular treatment of hemodialysis fistula in the forearm.
- Author
-
Matsuda H, Oka Y, Yoshida R, Katsura Y, Oyama T, Katsube R, Takatsu S, and Miyazaki M
- Subjects
- Graft Occlusion, Vascular diagnosis, Graft Occlusion, Vascular etiology, Humans, Pain etiology, Pain physiopathology, Prospective Studies, Treatment Outcome, Ultrasonography, Interventional, Anesthetics, Local administration & dosage, Angioplasty, Balloon adverse effects, Arteriovenous Shunt, Surgical adverse effects, Autonomic Nerve Block methods, Forearm blood supply, Forearm innervation, Graft Occlusion, Vascular therapy, Lidocaine administration & dosage, Pain prevention & control, Pain Threshold drug effects, Renal Dialysis
- Published
- 2016
- Full Text
- View/download PDF
20. Iron depletion enhances the effect of sorafenib in hepatocarcinoma.
- Author
-
Urano S, Ohara T, Noma K, Katsube R, Ninomiya T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Nouso K, Matsukawa A, Yamamoto K, and Fujiwara T
- Subjects
- Animals, Carcinoma, Hepatocellular mortality, Carcinoma, Hepatocellular pathology, Cell Proliferation, Disease Models, Animal, Female, Humans, Liver Neoplasms mortality, Liver Neoplasms pathology, Mice, Mice, Nude, Niacinamide administration & dosage, Niacinamide pharmacology, Niacinamide therapeutic use, Phenylurea Compounds administration & dosage, Phenylurea Compounds pharmacology, Prognosis, Retrospective Studies, Sorafenib, Survival Analysis, Carcinoma, Hepatocellular drug therapy, Iron pharmacology, Liver Neoplasms drug therapy, Niacinamide analogs & derivatives, Phenylurea Compounds therapeutic use
- Abstract
ABSTACT Human hepatocellular carcinoma (HCC) is known to have a poor prognosis. Sorafenib, a molecular targeted drug, is most commonly used for HCC treatment. However, its effect on HCC is limited in clinical use and therefore new strategies regarding sorafenib treatment are required. Iron overload is known to be associated with progression of chronic hepatitis and increased risk of HCC. We previously reported that iron depletion inhibited cancer cell proliferation and conversely induced angiogenesis. Indeed iron depletion therapy including iron chelator needs to be combined with anti-angiogenic drug for its anti-cancer effect. Since sorafenib has an anti-angiogenic effect by its inhibitory targeting VEGFR, we hypothesized that sorafenib could complement the anti-cancer effect of iron depletion. We retrospectively analyzed the relationship between the efficacy of sorafenib and serum iron-related markers in clinical HCC patients. In clinical cases, overall survival was prolonged in total iron binding capacity (TIBC) high- and ferritin low-patients. This result suggested that the low iron-pooled patients, who could have a potential of more angiogenic properties in/around HCC tumors, could be adequate for sorafenib treatment. We determined the effect of sorafenib (Nexavar®) and/or deferasirox (EXJADE®) on cancer cell viability, and on cell signaling of human hepatocarcinoma HepG2 and HLE cells. Both iron depletion by deferasirox and sorafenib revealed insufficient cytotoxic effect by each monotherapy, however, on the basis of increased angiogenesis by iron depletion, the addition of deferasirox enhanced anti-proliferative effect of sorafenib. Deferasirox was confirmed to increase vascular endothelial growth factor (VEGF) secretion into cellular supernatants by ELISA analysis. In in vivo study sorafenib combined with deferasirox also enhanced sorafenib-induced apoptosis. These results suggested that sorafenib combined with deferasirox could be a novel combination chemotherapy for HCC.
- Published
- 2016
- Full Text
- View/download PDF
21. Ultrasound-guided block of selective branches of the brachial plexus for vascular access surgery in the forearm: a preliminary report.
- Author
-
Matsuda H, Oka Y, Takatsu S, Katsube R, Yoshida R, Oyama T, Takeda Y, and Miyazaki M
- Subjects
- Aged, Aged, 80 and over, Amides adverse effects, Anesthetics, Combined adverse effects, Anesthetics, Local adverse effects, Arteriovenous Shunt, Surgical adverse effects, Brachial Plexus Block adverse effects, Female, Humans, Lidocaine adverse effects, Male, Middle Aged, Pain diagnosis, Pain etiology, Pain physiopathology, Pain Measurement, Pain Threshold drug effects, Pilot Projects, Ropivacaine, Treatment Outcome, Amides administration & dosage, Anesthetics, Combined administration & dosage, Anesthetics, Local administration & dosage, Arteriovenous Shunt, Surgical methods, Brachial Plexus Block methods, Forearm blood supply, Lidocaine administration & dosage, Pain prevention & control, Ultrasonography, Interventional
- Abstract
Purpose: The operative field for vascular access (VA) surgery in the forearm is on the volar surface, and motor nerve block is not necessary for regional anesthesia. Therefore, selective block of branches of the brachial plexus may be a more efficient anesthesia technique., Methods: Individual nerve blocks in the axillary brachial plexus and selective blocks of the musculocutaneous and medial antebrachial cutaneous nerves in the upper arm were performed using low doses and concentrations of a local anesthetic mixture of lidocaine and ropivacaine under ultrasound (US) guidance in patients undergoing VA surgery in the forearm. The targeted nerves were identified by continuous US tracing along the upper arm to the axilla in a short-axis view. We performed three VA surgeries in the forearm using an axillary brachial plexus block and four using a selective two-nerve bock in the upper arm. We recorded any additional anesthetic requirement and evaluated intraoperative pain using the Wong-Baker Faces Pain Rating Scale (WBFRS; 0 = no pain; 10 = worst pain)., Results: All of the target nerve branches were clearly identified by US tracing. All patients had satisfactory intraoperative pain control (0 or 2 score on WBFRS). Four patients required small additional doses of local anesthetic., Conclusions: US-guided block of individual branches of the brachial plexus at the axilla achieved effective anesthesia using small amounts of local anesthetic. An advanced selective nerve block in the upper arm allows minimum necessary anesthesia and provides safe and efficient analgesia for VA surgery in the forearm.
- Published
- 2016
- Full Text
- View/download PDF
22. [Therapeutic Potential of Targeting Cancer-Associated Fibroblasts in Esophageal Cancer].
- Author
-
Noma K, Kashima H, Ninomiya T, Katsube R, Watanabe S, Ohara T, Tazawa H, Kagawa S, Shirakawa Y, and Fujiwara T
- Subjects
- Endopeptidases, Esophageal Neoplasms pathology, Fibroblasts pathology, Gelatinases metabolism, Humans, Membrane Proteins metabolism, Serine Endopeptidases metabolism, Signal Transduction drug effects, Antineoplastic Agents pharmacology, Esophageal Neoplasms drug therapy, Fibroblasts enzymology
- Abstract
Advances in molecular and cellular biochemistry, such as the development of targeted cancer therapy, have dramatically improved the prognosis of cancer patients. Emerging data have suggested that bevacizumab treatment may act by controlling the cancer microenvironment. Many reports have examined the interaction of cancer cells with the tumor microenvironment, and cancer-associated fibroblasts (CAFs) are thought to play a central role in this process. We speculated that the cancer microenvironment and in particular, CAFs, strongly influence the development of esophageal cancer. We have analyzed the signaling pathways of molecular targets. However, inhibition of a single signaling pathway is insufficient to treat cancer effectively. Photoimmunotherapy is a molecular-targeted specific cancer therapy using near-infrared radiation, which was introduced by Mitsunaga et al. in 2011. We are using its specific method of killing cells to target CAFs. We will report the results of its effect on cancer cells in the future.
- Published
- 2015
23. Sevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in Japan.
- Author
-
Oka Y, Miyazaki M, Matsuda H, Takatsu S, Katsube R, Mori T, Takehara K, Umeda Y, and Uno F
- Subjects
- Acidosis chemically induced, Aged, Bicarbonates blood, Chelating Agents administration & dosage, Data Collection, Dose-Response Relationship, Drug, Drug Monitoring methods, Female, Humans, Japan, Logistic Models, Male, Middle Aged, Polyamines administration & dosage, Prevalence, Sevelamer, Severity of Illness Index, Acidosis epidemiology, Chelating Agents adverse effects, Polyamines adverse effects, Renal Dialysis
- Abstract
Metabolic acidosis has a negative impact on prognosis of dialysis patients. The aim of this study was to determine the prevalence of severe metabolic acidosis in dialysis patients treated with sevelamer hydrochloride. In 2004, a nationwide survey (101,516 dialysis patients) was conducted by the Japanese Society for Dialysis Therapy. We analyzed 32,686 dialysis patients whose bicarbonate levels were measured in the survey. Sevelamer hydrochloride was prescribed to 9231 dialysis patients while 23,455 dialysis patients were not prescribed sevelamer hydrochloride. In the present study, we defined severe acidosis as bicarbonate <15.8 mmol/L. The mean serum bicarbonate level correlated significantly and negatively with the daily dose of sevelamer hydrochloride (R(2) = 0.806, P < 0.0001). Logistic regression analysis indicated that the percentage of patients with severe acidosis increased significantly with increased dose of sevelamer hydrochloride (R(2) = 0.885, P < 0.00001). The estimated doses of sevelamer hydrochloride associated with severe acidosis in 10% and 15% of patients were 3.5 g/day (95% confidence interval [95%CI], 2.8-4.4) and 7.7 g/day (95%CI = 5.9-10.9), respectively. Severe acidosis was noted in 4.5% of patients who were not treated with sevelamer hydrochloride and in 16.1% of patients treated with sevelamer hydrochloride at ≥ 5.25 g/day (P < 0.0001). The results call for careful monitoring of serum bicarbonate level in hemodialysis patients treated with sevelamer hydrochloride., (© 2013 The Authors. Therapeutic Apheresis and Dialysis © 2013 International Society for Apheresis.)
- Published
- 2014
- Full Text
- View/download PDF
24. Assistant-based standardization of prone position thoracoscopic esophagectomy.
- Author
-
Shirakawa Y, Noma K, Maeda N, Katsube R, Tanabe S, Ohara T, Sakurama K, and Fujiwara T
- Subjects
- Adenocarcinoma secondary, Adenocarcinoma surgery, Aged, Carcinoma, Neuroendocrine pathology, Carcinoma, Neuroendocrine surgery, Carcinoma, Squamous Cell secondary, Ergonomics, Esophageal Neoplasms pathology, Esophagectomy methods, Female, Humans, Lymph Node Excision methods, Lymph Node Excision standards, Lymphatic Metastasis, Male, Middle Aged, Operative Time, Patient Positioning methods, Postoperative Complications prevention & control, Prone Position, Thoracoscopy methods, Carcinoma, Squamous Cell surgery, Esophageal Neoplasms surgery, Esophagectomy standards, Patient Positioning standards, Surgeons, Thoracoscopy standards
- Abstract
Thoracoscopic esophagectomy in the prone position (TEPP) might enable solo-surgery in cases requiring resection of the esophagus and the surrounding lymph nodes due to the associated advantages of good exposure of the surgical field and ergonomic considerations for the surgeon. However, no one approach can be for all patients requiring extensive lymphadenectomy. We recently developed an assistant-based procedure to standardize exposure of the surgical field. Patients were divided into 1 of 2 groups:a pre-standardization group (n=37) and a post-standardization group (n=28). The thoracoscopic operative time was significantly shorter (p=0.0037) in the post-standardization group (n=28; 267 ± 31 min) than in the pre-standardization group (n=37;301 ± 53 min). Further, learning curve analysis using the moving average method showed stabilization of the thoracoscopic operative time after the standardization. No significant differences were found in the number of mediastinal lymph nodes dissected or intraoperative blood loss between the 2 groups. There were also no significant differences in the complication rate. Assistant-based surgery and standardization of the procedure resulted in a well-exposed and safe surgical field. TEPP decreased the operative time, even in patients requiring extensive lymphadenectomy.
- Published
- 2014
- Full Text
- View/download PDF
25. [Current status of neoadjuvant chemotherapy for advanced esophageal cancer].
- Author
-
Tanabe S, Shirakawa Y, Maeda N, Katsube R, Ohara T, Sakurama K, Noma K, and Fujiwara T
- Subjects
- Aged, Aged, 80 and over, Cisplatin administration & dosage, Docetaxel, Esophageal Neoplasms pathology, Esophageal Neoplasms surgery, Female, Fluorouracil administration & dosage, Humans, Male, Middle Aged, Neoplasm Staging, Taxoids administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Esophageal Neoplasms drug therapy, Neoadjuvant Therapy
- Abstract
Since reported in the JCOG9907 trial, neoadjuvant chemotherapy prior to surgery has become the standard treatment for advanced (Stage II/III) esophageal cancers. However, more powerful neoadjuvant chemotherapy is required for the treatment of locally advanced cases or cases involving multiple lymph node metastases. At our institute, DCF therapy (docetaxel, cisplatin, and 5-fluorouracil) is administered selectively for the treatment of patients with far-advanced esophageal cancer. We treated 53 thoracic esophageal cancer patients who underwent surgery following neoadjuvant chemotherapy between January 2010 and December 2012. FP therapy (cisplatin and 5-fluorouracil) was administered to 43 patients, and DCF therapy to 7 patients who had far-advanced esophageal cancer. All patients treated with DCF therapy experienced grade 3 and 4 adverse events. With the exception of 1 patient, all patients who received DCF therapy could undergo curative surgery. DCF therapy could become an effective preoperative chemotherapy.
- Published
- 2013
26. Successfully treated pneumatosis cystoides intestinalis with pneumoperitoneum onset in a patient administered α-glucosidase inhibitor.
- Author
-
Tanabe S, Shirakawa Y, Takehara Y, Maeda N, Katsube R, Ohara T, Sakurama K, Noma K, and Fujiwara T
- Subjects
- Administration, Oral, Aged, 80 and over, Female, Humans, Hypoglycemic Agents administration & dosage, Pneumatosis Cystoides Intestinalis therapy, Pneumoperitoneum therapy, Diabetes Mellitus, Type 2 drug therapy, Glycoside Hydrolase Inhibitors, Hypoglycemic Agents adverse effects, Pneumatosis Cystoides Intestinalis chemically induced, Pneumoperitoneum chemically induced
- Abstract
An 80-year-old woman, who had been administered α-glucosidase inhibitor for diabetes, was brought to the hospital with the sensation of abdominal fullness and pain. Abdominal computed tomography indicated pneumatosis cystoides intestinalis (PCI) in the small intestinal wall, with free air within the abdomen. A blood examination showed no increases in white blood cells or C-reactive protein level. The patient's condition improved with conservative therapy. PCI with pneumoperitoneum induced by α-glucosidase inhibitor is rare, with only 27 cases (excluding the present case) reported in Japan to date. In PCI with pneumoperitoneum, differentiation from gastrointestinal perforation is important and following the clinical symptoms over time is vital.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.